Latest News

Kashi Clinical Laboratories now performs T-SPOT.TB® testing in-house, a CDC-recognized IGRA test for TB infection. This update delivers improved result insights for older patient populations, requires significantly reduced specimen volume requirements, and delivers faster turnaround times compared to the previous QuantiFERON testing method.

Due to the widespread winter storm, we have received limited specimens on Monday, January 26 and Tuesday, January 27. We will prioritize processing samples as soon as we receive them and appreciate your understanding as we work through any shipping and delivery delays which have been caused by the adverse weather conditions.

Our team will be attending, presenting, and/or exhibiting as a sponsor at the following events in 2025. We love meeting up with clients and partners and connecting with new colleagues to explore ways we can accelerate and improve outcomes for patients together.

Kashi Clinical Laboratories (KCL), a market leader in transplantation immunodiagnostic lab testing, has recently expanded it's collaboration with Thermo Fisher Scientific and Transcriptome Sciences to deliver Molecular Microscope® Diagnostic System for Lung.

Kashi Clinical Laboratories (KCL) recently achieved two-year reaccreditation from the College of American Pathologists (CAP), the world’s leading provider of laboratory accreditation and proficiency testing programs.